First human test for new asthma pill begins
NCT ID NCT07272135
Summary
This was an early safety study for a new oral medication called TR4, designed for people with mild-to-moderate asthma. It involved 12 patients who took either the drug or a placebo (dummy pill) in increasing doses over several weeks. The main goals were to see if the drug was safe and how it affected their breathing and lung function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hammersmith Medicines Research
London, London, NW10 7EW, United Kingdom
Conditions
Explore the condition pages connected to this study.